Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Allocated but not treated: the silent 16% - Authors' reply.


Horby P. et al, (2022), Lancet, 399, 1775 - 1776

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group Writing Committee: None. et al, (2021), Eur Heart J

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Journal article

Horby PW. et al, (2021), Lancet Respiratory Medicine, 9, 1419 - 1426

Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.

Working paper

Horby P. et al, (2021), Lancet, 398

Load More